Back
Emergent BioSolutions Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
30
EBS
Emergent BioSolutions
Last Price:
$8.27
Seasonality Move:
-0.51%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EBS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Emergent BioSolutions Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.28 | Sell |
| 20-day SMA: | 8.75 | Sell |
| 50-day SMA: | 9.21 | Sell |
| 200-day SMA: | 7.21 | Buy |
| 8-day EMA: | 8.35 | Sell |
| 20-day EMA: | 8.65 | Sell |
| 50-day EMA: | 8.88 | Sell |
| 200-day EMA: | 7.77 | Buy |
Emergent BioSolutions Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 42.46 | Sell |
| Chaikin Money Flow: | 471292 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.3 - 9.62) | Sell |
| Bollinger Bands (100): | (7.49 - 9.93) | Sell |
Emergent BioSolutions Technical Analysis
| Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Emergent BioSolutions Stock
Is Emergent BioSolutions Stock a Buy?
-
Emergent BioSolutions share price is 8.27 while EBS 8-day simple moving average is 8.28, which is a Sell signal.
-
The stock price of EBS is 8.27 while Emergent BioSolutions 20-day SMA is 8.75, which makes it a Sell.
-
Emergent BioSolutions 50-day simple moving average is 9.21 while EBS share price is 8.27, making it a Sell technically.
-
EBS stock price is 8.27 and Emergent BioSolutions 200-day simple moving average is 7.21, creating a Buy signal.
EBS Technical Analysis vs Fundamental Analysis
Sell
30
Emergent BioSolutions (EBS)
is a Sell
Is Emergent BioSolutions a Buy or a Sell?
-
Emergent BioSolutions stock is rated a SellThe current Emergent BioSolutions [EBS] share price is $8.27. The Score for EBS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Emergent BioSolutions Stock Info
Market Cap:
448.1M
Price in USD:
8.27
Share Volume:
785.5K
Emergent BioSolutions 52-Week Range
52-Week High:
15.10
52-Week Low:
1.42
Sell
30
Emergent BioSolutions (EBS)
is a Sell
Emergent BioSolutions Share Price Forecast
-
What is the Emergent BioSolutions stock price today?The Emergent BioSolutions stock price is 8.27 USD today.
-
Will EBS stock go up or go down?Emergent BioSolutions> share price is forecast to RISE/FALL based on technical indicators
-
Is Emergent BioSolutions overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Emergent BioSolutions is overvalued.
Is Emergent BioSolutions Stock a Buy?
-
Emergent BioSolutions share price is 8.27 while EBS 8-day exponential moving average is 8.35, which is a Sell signal.
-
The stock price of EBS is 8.27 while Emergent BioSolutions 20-day EMA is 8.65, which makes it a Sell.
-
Emergent BioSolutions 50-day exponential moving average is 8.88 while EBS share price is 8.27, making it a Sell technically.
-
EBS stock price is 8.27 and Emergent BioSolutions 200-day simple moving average is 7.77, creating a Buy signal.
Fundamental Analysis of Emergent BioSolutions
Is Emergent BioSolutions a good investment?
-
Analysts estimate an earnings increase this quarter of $0.99 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.06 per share, and an increase next year of $2.88 per share.
Technical Analysis of Emergent BioSolutions
Should I short Emergent BioSolutions stock?
-
EBS Moving Average Covergence Divergence (MACD) indicator is -0.3, suggesting Emergent BioSolutions is a Sell
-
Emergent BioSolutions Relative Strength Index (RSI) is 42.46, which suggest Emergent BioSolutions is oversold
-
The Bollinger Bands (25) for Emergent BioSolutions is (8.3 - 9.62), which suggest Emergent BioSolutions is a Sell
-
The Bollinger Bands (100) for Emergent BioSolutions is (7.49 - 9.93), which suggest Emergent BioSolutions is a Sell
* Emergent BioSolutions stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.